• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제20권3호
• /
• pp.139-146
• /
• 2017

The number of papers discussing probiotics increases tremendously that limits the possibility for primary care physicians and clinicians to stay updated. Therefore, the aim of this paper will be to summarize available evidence of probiotic use in well-defined clinical indications of importance for pediatricians. Based on currently available evidence certain probiotic strains (Lactobacillus rhamnosus GG [LGG] and Saccharomyces boulardii) have proven effect in the treatment of acute gastroenteritis and prevention of antibiotic associated diarrhea. Furthermore, LGG was proven to be effective in prevention of nosocomial diarrhea and respiratory tract infection in day care centers. In conclusion, not all probiotic strains have same efficacy for all clinical indications, therefore, only strains with proven efficacy and safety should be recommended.

• Journal of Microbiology and Biotechnology
• /
• 제27권11호
• /
• pp.1971-1982
• /
• 2017

Piliated Lactobacillus rhamnosus (pLR) strains possess higher adherent capacity than non-piliated strains. The objective of this study was to isolate and characterize probiotic pLR strains in human fecal samples. To this end, mouse polyclonal antiserum (anti-SpaA) against the recombinant pilus protein (SpaA) of L. rhamnosus strain GG (LGG) was prepared and tested for its reactivity and specificity. With the anti-SpaA, a method combining the de Man, Rogosa, and Sharpe (MRS) agar plating separation and colony immunoblotting (CIB) was developed to isolate pLR from 124 human fecal samples. The genetic and phenotypic characteristics of the resultant pLR isolates were compared by randomly amplified polymorphic DNA (RAPD) fingerprinting, and examination of adhesion to Caco-2 cells, hydrophobicity, autoaggregation, and in vitro gastrointestinal tolerance. Anti-SpaA specifically reacted with three pLR strains of 25 test strains, as assessed by western blotting, immunofluorescence flow cytometry, and immunoelectron microscopy (IEM) assays. The optimized MRS agar separation plus anti-SpaA-based CIB procedure could quantitatively detect $2.5{\times}10^3CFU/ml$ of pLR colonies spiked in $10^6CFU/ml$ of background bacteria. Eight pLR strains were identified in 124 human fecal samples, and were confirmed by 16S RNA gene sequencing and IEM identification. RAPD fingerprinting of the pLR strains revealed seven different patterns, of which only two isolates from infants showed the same RAPD profiles with LGG. Strain PLR06 was obtained with high adhesion and autoaggregation activities, hydrophobicity, and gastrointestinal tolerance. Anti-SpaA-based CIB is a rapid and inexpensive method for the preliminary screening of novel adherent L. rhamnosus strains for commercial purposes.

• Journal of Microbiology and Biotechnology
• /
• 제29권8호
• /
• pp.1248-1254
• /
• 2019

Identification of novel probiotic strains is of great interest in the field of functional foods. Specific strains of heat-killed bacteria have been reported to exert immunomodulatory effects. Herein, we investigated the immune-stimulatory function of heat-killed Lactobacillus plantarum KCTC 13314BP (LBP). Treatment with LBP significantly increased the production of $TNF-{\alpha}$ and IL-6 by macrophages. More importantly, LBP was able to enhance the phagocytic activity of macrophages against bacterial particles. Activation of p38, JNK, ERK, $NF-{\kappa}B$, and STAT3 was involved in the immunomodulatory function of LBP. LBP treatment significantly increased production of $TNF-{\alpha}$ by bone marrow-derived macrophages and splenocytes, further confirming the immunostimulatory effect of LBP in primary immune cells. Interestingly, the immunomodulatory effects of LBP were much stronger than those of Lactobacillus rhamnosus GG, a well-known probiotic strain. These results indicate that LBP can be a promising immune-enhancing functional food agent.

• Journal of Microbiology and Biotechnology
• /
• 제31권5호
• /
• pp.726-732
• /
• 2021

In this study, we evaluated the immune-enhancing activity of kimchi-derived Lactobacillus plantarum 200655 on immune suppression by cyclophosphamide (CP) in ICR mice. Animals were fed distilled water or 1×10⁹ colony-forming unit/kg B.W. 200655 or Lactobacillus rhamnosus GG as a positive control for 14 days. An in vivo model of immunosuppression was induced using CP 150 and 100 mg/kg B.W. at 7 and 10 days, respectively. Body weight, spleen index, spleen weight, and gene expression were measured to estimate the immune-enhancing effects. The dead 200655 (D-200655) group showed an increased spleen weight compared to the sham control (SC) group. Similarly, the spleen index was significantly higher than that in the CP-treated group. The live 200655 (L-200655) group showed an increased mRNA expression of tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-6 in splenocytes. Also, the iNOS and COX-2 mRNA expression was upregulated in the L-200655 group compared to the CP-only (SC) group. The phosphorylation of ERK and MAPK was also upmodulated in the L-200655 group. These results indicate that L. plantarum 200655 ameliorated CP-induced immune suppression, suggesting that L. plantarum 200655 may have the potential to enhance the immune system.

• Journal of Microbiology and Biotechnology
• /
• 제26권7호
• /
• pp.1333-1340
• /
• 2016

The main objective of this study was to investigate whether Lactobacillus rhamnosus GG (LGG) ameliorated the effects of Citrobactor rodentium infection in Toll-like receptor 2 (TLR2) knockout (KO) and TLR4 KO mice, as well as in wild-type C57BL/6 (B6) mice. TLR2 KO, TLR4 KO, and B6 mice were divided into three groups per each strain. Each group had an uninfected control group (n = 5), C. rodentium-infected group (n = 8), and LGG-pretreated C. rodentium-infected group (n = 8). The survival rate of B6 mice infected with C. rodentium was higher when pretreated with LGG. Pretreatment with LGG ameliorated C. rodentium-induced mucosal hyperplasia in B6 and TLR4 KO mice. However, in C-rodentium-infected TLR2 KO mice, mucosal hyperplasia persisted, regardless of pretreatment with LGG. In addition, LGG-pretreated B6 and TLR4 KO mice showed a decrease in spleen weight and downregulation of tumor necrosis factor alpha, interferon gamma, and monocyte chemotactic protein 1 mRNA expression compared with the non-pretreated group. In contrast, such changes were not observed in TLR2 KO mice, regardless of pretreatment with LGG. From the above results, we conclude that pretreatment with LGG ameliorates C. rodentium-induced colitis in B6 and TLR4 KO mice, but not in TLR2 KO mice. Therefore, LGG protects mice from C. rodentium-induced colitis in a TLR2-dependent manner.

• Journal of Dairy Science and Biotechnology
• /
• 제37권4호
• /
• pp.223-236
• /
• 2019

본 연구는 김치로부터 비만 억제능력이 있는 젖산균을 분리 및 동정하고, 이 균주의 생리적 특성을 규명하여 상업적으로의 이용가능성을 검토하고자 실시하였다. 이를 위해 Modified MRS 분별배지를 사용하여 노란색 집락을 형성하는 균주를 대상으로 각각 α-amylase inhibitory activity, α-glucosidase inhibitory activity와 단쇄지방산 생산이 우수한 균주를 선발한 결과, KI69 균주가 최종 선발되었다. KI69 균주는 α-amylase억제활성 91.17±2.23%, α-glucosidase 억제활성 98.71±4.23%, 단쇄지방산인 프로피온산, 에세트산, 브티르산이 MRS broth에서 각각 8.78±1.12 ppm, 1.34±0.07%(w/v), 0.876±0.003 g/kg이 나타났으며, 동정결과 L. plantarum으로 판명되었고, L. plantarum KI69로 명명하였다. L. plantarum KI69는 답즙산과 산성의 pH에서 모두 우수한 생존력을 나타내었고, 효소활성은 β-galactosidase, β-glucosidase와 N-acetyl-β-glucosaminidase에 대해 높은 효소 활성을 나타내었다. 항생제 내성 실험 결과 vancomycin에 내성이 있는 반면 penicillin-G와rifampicin에 감수성을 나타냈으며, Escherichia coli, Salmonella Typhimurium, Listeria monocytogenes와 Staphyloccous aureus에 대해 각각 15.44%, 50.79%, 58.62%와 37.85%의 억제 효과를 지니고 있는 것으로 나타났다. 장 부착성은 대조구인 L. rhamnosus GG보다 우수하였다.

• Journal of Dairy Science and Biotechnology
• /
• 제38권4호
• /
• pp.207-221
• /
• 2020

This study aimed to investigate the physiological characteristics and anti-obesity effects of milk fermented by L. plantarum KI134. The lipase, α-amylase, and α-glucosidase inhibitory activities of milk fermented by L. plantarum KI134 was 94.57±1.25%, 9.44±2.85%, and 2.74±1.24% (10 fold dilution), respectively. L. plantarum KI134 showed higher sensitivity to clindamycin and erythromycin in comparison to sixteen different antibiotics. It demonstrated the highest resistance toward ampicillin and vancomycin. The strain showed higher β-galactosidase, leucine arylamidase, valine arylamidase, acid phosphatase, β-glucosidase, and N-acetyl-β-glucosaminidase activities compared to other enzymes. It also did not produce carcinogenic enzymes, such as β-glucuronidase. The survival rate of L. plantarum KI134 in 0.3% bile was 96.90%. Moreover, the strain showed a 91.45% survival rate at a pH of 2.0. L. plantarum KI134 has resistance to Escherichia coli, Salmonella Typhimurium, Listeria monocytogenes, and Staphylococcus aureus at the rates of 70.00%, 68.18%, 59.05%, and 40.63%, respectively. L. plantarum KI134 (23.01%) showed higher adhesion ability than the positive control (16.32%) L. rhamnosus GG. These results demonstrated that milk fermented by L. plantarum KI134 demonstrated an anti-obesity effect under in vitro conditions, with confirmed potential as a probiotic.

• Journal of Microbiology and Biotechnology
• /
• 제34권3호
• /
• pp.589-595
• /
• 2024

Latilactobacillus curvatus BYB3 (BYB3) is a species of lactic acid bacteria, formerly named Lactobacillus curvatus, which is isolated from kimchi. In this study, the effect of BYB3, Lactobacillus rhamnosus GG, and Lactobacillus acidophilus GP1B strain extracts at various concentrations was examined on B16F10, a mouse melanoma cell line. Cell viability was examined via MTT assay, and the results indicated that compared to the other two probiotics, BYB3 significantly decreased the total percentages of viable cells. The effects of BYB3 on cell migration and proliferation in B16F10 cells were evaluated using wound healing mobility and proliferation assays, respectively; the results indicated that BYB3 inhibits cell migration and proliferation in a concentration-dependent manner. Using human dermal fibroblast cells to investigate BYB3 extract in vivo had no effect on skin-related cells. Nonetheless, the BYB3 extract inhibited tumor growth in a mouse model, as demonstrated by liver slices. Therefore, this suggests that using BYB3 extract to inhibit melanoma may be a novel approach.

• 한국식품과학회지
• /
• 제53권2호
• /
• pp.204-212
• /
• 2021

본 연구에서는 살아있는 프로바이오틱스 균주에 의한 레자주린의 흡광 및 형광특성의 변화와 레소루핀과의 반응성을 분석하고, 균주별 레자주린에 대한 환원능을 비교하였다. LGG에 의해 레자주린은 흡광과 형광의 변화를 수반하며 레소루핀으로 환원되고 반응시간과 생균수의 증가에 따라 환원정도가 증가하였으며, 형광의 변화에서 더 정확하고 민감한 반응성을 보였다. 한편 LGG에 의한 레소루핀으로부터 다이하이드로레소루핀으로의 환원반응은 거의 유발되지 않았다. 프로바이오틱스 6개 균주 중 L. kimchicus의 생균에 의한 레자주린 환원력이 월등하게 높은 반면, 균체 파쇄 후의 ABTS 및 DPPH 라디칼 소거능은 다른 양상을 보이며 L. plantarum과 L. casei가 높은 활성을 나타냈다. 한편 생균의 MTT 환원능은 L. kimchicus가 LGG에 비해 현저히 높아 레자주린 환원능과 유사한 양상을 보였다. 본 연구결과는 레자주린이 단일 균주 프로바이오틱스의 생균수 측정에 유용하며, 프로바이오틱스의 선별 및 환원활성 측정에 활용될 수 있음을 시사한다.

• 식품과학과 산업
• /
• 제44권1호
• /
• pp.59-62
• /
• 2011

전세계적으로 감염성 질환은 주요한 건강 문제이다. 장내 미생물 균총은 해로운 미생물로부터 숙주를 보호할 뿐 아니라 면역계에 있어서 매우 중요한 역할을 한다. 이점이 바로 프로바이오틱스 즉, 건강에 도움을 주며 살아있는 미생물로 정의되는 기본 개념을 탄생시켰다. Lactobacillus rhamnosus GG(이하 LGG) 균은 세계적으로 가장 많이 연구된 프로바이오틱스 균종 중 하나로서, 확인된 효능의 대부분은 주로 위장관 질환에 관한 것이다. 몇몇 연구를 통해 급성 수양성 설사의 치료, 항생제 관련 증상의 예방, 그리고 여행자 설사에 대한 LGG균의 효과가 밝혀졌다. LGG균은 소아에서 호흡기 감염의 발생을 줄이거나 그 합병증을 감소시키는 것으로 보인다. 많은 연구를 통해 LGG 균, LC705, 그리고 프로피오니박테리움 PJS균을 모두 포함한 복합 유산균 제제인 $LGG^{(R)}$ Extra가 위장관 불편감을 줄이고 삶의 질을 향상시키는 것으로 나타났다. 따라서 LGG균의 사용은 감염성 질병의 관리와 위장관 건강을 얻는데 있어 안전하고 쉬운 방법이라 하겠다.